Legal status · Australia
Is Ribupatide legal in Australia?
No. Ribupatide is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Ribupatide in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Evidence level | Moderate (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Ribupatide profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
Ribupatide is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Ribupatide is
A once-weekly GLP-1/GIP dual agonist in the tirzepatide class that delivered 19.2% weight loss at 48 weeks in a Chinese Phase 3 trial and is now in global pivotal studies at higher doses.
Ribupatide is Hengrui's dual incretin agonist, licensed outside China to Kailera Therapeutics. 4%.
Mechanism: Simultaneous agonism of the GLP-1 and GIP receptors, the same dual-incretin approach as tirzepatide.
Regulatory history: Investigational in the US; under regulatory review in China
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Ribupatide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Ribupatide in other countries
Frequently asked questions
Is Ribupatide legal in Australia?
No. Ribupatide is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Ribupatide in Australia?
No approved product exists to buy. In Australia Ribupatide is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Ribupatide TGA approved?
No. In Australia Ribupatide is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational in the US; under regulatory review in China. Evidence level: Moderate.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Ribupatide live on its compound profile.
Ribupatide profileThis page is general information about the regulatory status of Ribupatide in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.